Cargando…
Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study
BACKGROUND: Saliva is often used as a biomarker for the diagnosis of some oral and systematic diseases, owing to the non‐invasive attribute of the fluid. In this study, we aimed to identify salivary biomarkers for distinguishing lung cancer (LC) from benign lung lesion (BLL). MATERIALS AND METHODS:...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807259/ https://www.ncbi.nlm.nih.gov/pubmed/34918488 http://dx.doi.org/10.1111/1759-7714.14282 |